BOLT News & Analysis

Bolt Biotherapeutics (BOLT) CEO Sells $58,402 in Company Stock

Quinn, the CEO of Bolt Biotherapeutics, sold shares worth $58,402. This transaction raises questions about insider confidence in the company's future prospects. Such sales can affect market perception and investor sentiment. Depending on future stock performance, this transaction could influence how investors view Bolt Biotherapeutics (BOLT) moving forward.